.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Hospitalized patients with opioid use disorder (OUD) often face significant hurdles during acute medical care. These individuals frequently experience patient-directed discharge (PDD) and incomplete antibiotic regimens. Consequently, clinicians must evaluate effective Opioid withdrawal management strategies to ensure successful treatment of serious infections like bacteremia. A recent retrospective study at Temple University Hospital highlights the critical differences between two common approaches: Medications for Opioid Use Disorder (MOUD) and high-dose opioid agonist therapy (HDOAT).
The study analyzed 383 patient encounters involving OUD and bacteremia between 2020 and 2022. Researchers compared patients receiving MOUD, such as methadone and buprenorphine, against those receiving HDOAT alone. In this context, HDOAT involved full agonists like oxycodone or hydromorphone at doses reaching up to 2,070 Morphine Milligram Equivalents (MMEs) per day. Surprisingly, despite the high doses used in the HDOAT group, the clinical outcomes favored the MOUD group significantly.
Notably, MOUD was associated with a much higher rate of antibiotic completion. Specifically, 35.0% of patients in the MOUD group finished their full course, compared to only 23.3% in the HDOAT group. Furthermore, MOUD significantly reduced the risk of patient-directed discharge. These findings suggest that stabilizing the underlying addiction with evidence-based medications is more effective than simply masking withdrawal symptoms with high-dose full agonists. Therefore, clinicians should prioritize the initiation of methadone or buprenorphine over traditional opioid-based comfort measures.
In addition to antibiotic adherence, the study observed a trend toward lower one-year mortality in the MOUD group. Although the differences in short-term readmission rates were less pronounced, the long-term benefit of stabilizing OUD during a medical crisis remains clear. Moreover, managing bacteremia requires a stable, long-term therapeutic environment because these infections necessitate weeks of antimicrobial therapy. Integrating addiction specialists into the care of patients with injection-related infections can bridge the gap between acute medicine and long-term recovery.
MOUD involves FDA-approved medications like buprenorphine or methadone specifically for long-term recovery. In contrast, HDOAT refers to using high doses of full opioid agonists (e.g., oxycodone) primarily to manage acute withdrawal symptoms without the stabilization benefits of MOUD.
MOUD effectively reduces cravings and stabilizes the patient's neurological state. This stabilization allows the patient to remain in the hospital for the duration of the antibiotic course, reducing the likelihood of leaving against medical advice.
While HDOAT may provide temporary relief, the study suggests it is less effective than MOUD at improving clinical outcomes. Most experts recommend transitioning to MOUD as early as possible during the hospital stay.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Handy S et al. Comparative outcomes of opioid withdrawal management strategy in patients with injection-related bacteremia. J Addict Dis. 2026 Jun 15. doi: 10.1080/10550887.2026.2685063. PMID: 42290474.
Lewis S et al. Patients with serious injection drug use-related infections who experience patient-directed discharges on oral antibiotics have high rates of antibiotic adherence but require multidisciplinary outpatient support. Open Forum Infect Dis. 2022;9(2):ofab633.
Alrawashdeh M et al. Epidemiology, Outcomes, and Trends of Patients With Sepsis and Opioid-Related Hospitalizations in U.S. Hospitals. Crit Care Med. 2021;49(12):2102-2111.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A comparative study at Temple University Hospital shows that Medications for Opioid Use Disorder (MOUD) significantly outperform high-dose opioid agonist therapy (HDOAT) in achieving antibiotic completion and reducing mortality for patients with injection-related bacteremia.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
